Current Treatments For Diabetes Type 2, Osteoporosis, And Hypertension Induced By Glucocorticoids

Abstract

Glucocorticoids, effective in treating inflammation, can lead to metabolic and skeletal complications, including diabetes type 2, osteoporosis, and hypertension. These complications present significant challenges in clinical management. Unders[1]tanding the underlying mechanisms is crucial for effective management. Lifestyle modifications like dietary changes, weight management, and regular exercise can help mitigate these complications. Pharmacological interventions like antidiabetic medications, bone-strengthening agents, and antihypertensive drugs are often necessary for optimal outcomes. Emerging therapies, such as GLP-1 receptor agonists and SGLT-2 inhibitors, offer promise in addressing these complications. A multifaceted approach involving lifestyle modifications, pharmacological interventions, and emerging therapies is necessary to better meet the needs of patients receiving glucocorticoid therapy and improve their overall quality of life.